Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Khasraw

Showing results (21-30 of 176) with videos related to

Pageof 18
Sort By:
International Journal of Molecular Sciences|February 26, 2020
Brain Metastases in Lung Cancers with Emerging Targetable Fusion DriversAaron C Tan, Malinda Itchins, Mustafa Khasraw
Current Oncology Reports|November 6, 2010
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?Mustafa Khasraw, Edi Brogi, Andrew D Seidman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2020
Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 PandemicAaron C Tan, David M Ashley, Mustafa Khasraw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?John H Strickler, Brent A Hanks, Mustafa Khasraw
The Journal of Clinical Investigation|April 1, 2024
Soluble immune-checkpoint factors: a potential immunotherapy biomarkerAaron C Tan, Sarah L Cook, Mustafa Khasraw
Trends in Cancer|January 30, 2022
Low tumor mutational burden and immunotherapy in gliomasMichael C Brown, David M Ashley, Mustafa Khasraw
Current Oncology Reports|March 18, 2017
Immune Checkpoint Inhibitors in GliomasAaron C Tan, Amy B Heimberger, Mustafa Khasraw
Neuro-Oncology|November 6, 2023
A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline gliomaKelly M Hotchkiss, Eugene J Cho, Mustafa Khasraw
BMC Medicine|November 6, 2012
Using lithium as a neuroprotective agent in patients with cancerMustafa Khasraw, David Ashley, Greg Wheeler, et al.
Anti-Cancer Drugs|June 9, 2015
CDK4/6 inhibitors in breast cancerTim Dukelow, Divya Kishan, Mustafa Khasraw, et al.
Pageof 18

Showing results (21-30 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Molecular Sciences|February 26, 2020
Brain Metastases in Lung Cancers with Emerging Targetable Fusion DriversAaron C Tan, Malinda Itchins, Mustafa Khasraw
Current Oncology Reports|November 6, 2010
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?Mustafa Khasraw, Edi Brogi, Andrew D Seidman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2020
Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 PandemicAaron C Tan, David M Ashley, Mustafa Khasraw
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?John H Strickler, Brent A Hanks, Mustafa Khasraw
The Journal of Clinical Investigation|April 1, 2024
Soluble immune-checkpoint factors: a potential immunotherapy biomarkerAaron C Tan, Sarah L Cook, Mustafa Khasraw
Trends in Cancer|January 30, 2022
Low tumor mutational burden and immunotherapy in gliomasMichael C Brown, David M Ashley, Mustafa Khasraw
Current Oncology Reports|March 18, 2017
Immune Checkpoint Inhibitors in GliomasAaron C Tan, Amy B Heimberger, Mustafa Khasraw
Neuro-Oncology|November 6, 2023
A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline gliomaKelly M Hotchkiss, Eugene J Cho, Mustafa Khasraw
BMC Medicine|November 6, 2012
Using lithium as a neuroprotective agent in patients with cancerMustafa Khasraw, David Ashley, Greg Wheeler, et al.
Anti-Cancer Drugs|June 9, 2015
CDK4/6 inhibitors in breast cancerTim Dukelow, Divya Kishan, Mustafa Khasraw, et al.
Pageof 18